Michael King
Stock Analyst at EF Hutton
(1.01)
# 3,562
Out of 4,711 analysts
126
Total ratings
34.15%
Success rate
-16.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $1,100 → $650 | $9.75 | +6,566.67% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $1,179 | $1.56 | +75,489.74% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $3.15 | +249.76% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $4.23 | +656.50% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $21.57 | +217.57% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics Holdings | Assumes: Buy | $10 | $0.14 | +6,967.14% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $1.59 | +422.01% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $701.85 | +22.82% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $33.29 | -27.91% | 10 | Apr 28, 2023 | |
| OCEA Ocean Biomedical | Maintains: Buy | $10 → $17 | $0.66 | +2,459.86% | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $166 | $2.83 | +5,765.72% | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $24.13 | +74.06% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $304 | $245.44 | +23.86% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $116 | $12.18 | +852.38% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.38 | +646.38% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $28 | $0.21 | +13,420.04% | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $44.78 | -46.40% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $1.55 | +51,512.90% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $46 | $14.55 | +216.15% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $96 | $35.42 | +171.03% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.28 | +2,712.50% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.58 | +1,968.97% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $7.84 | +295.41% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $180 → $160 | $0.20 | +79,900.00% | 4 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $33 → $36 | $623.82 | -94.23% | 2 | Nov 13, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $1,100 → $650
Current: $9.75
Upside: +6,566.67%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $1.56
Upside: +75,489.74%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $3.15
Upside: +249.76%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $4.23
Upside: +656.50%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $21.57
Upside: +217.57%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $10
Current: $0.14
Upside: +6,967.14%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $1.59
Upside: +422.01%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $701.85
Upside: +22.82%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $33.29
Upside: -27.91%
Ocean Biomedical
Apr 27, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $0.66
Upside: +2,459.86%
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $2.83
Upside: +5,765.72%
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $24.13
Upside: +74.06%
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $245.44
Upside: +23.86%
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $12.18
Upside: +852.38%
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $1.38
Upside: +646.38%
Mar 30, 2022
Maintains: Buy
Price Target: $25 → $28
Current: $0.21
Upside: +13,420.04%
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $44.78
Upside: -46.40%
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $1.55
Upside: +51,512.90%
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $14.55
Upside: +216.15%
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $35.42
Upside: +171.03%
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $1.28
Upside: +2,712.50%
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $0.58
Upside: +1,968.97%
Nov 5, 2021
Maintains: Buy
Price Target: $25 → $31
Current: $7.84
Upside: +295.41%
Oct 18, 2019
Maintains: Market Outperform
Price Target: $180 → $160
Current: $0.20
Upside: +79,900.00%
Nov 13, 2017
Maintains: Market Outperform
Price Target: $33 → $36
Current: $623.82
Upside: -94.23%